Home > Name List By e > Erythropoietin[30-asparagine,32-threonine,87-valine,88-asparagine,90-threonine] (human)

CAS No 209810-58-2 , Erythropoietin[30-asparagine,32-threonine,87-valine,88-asparagine,90-threonine] (human)

  • Name: Erythropoietin[30-asparagine,32-threonine,87-valine,88-asparagine,90-threonine] (human)
  • Synonyms: Novelerythropoiesis stimulating protein; Nespo; Darbepoetin alfa;Darbepoetin;Erythropoietin[30-asparagine,32-threonine,87-valine,88-asparagine,90-threonine] (human); Ostogenes protein 1; NESP;Aranesp; Darbepoetin-a; KRN 321; Darbepoetin alpha;
  • CAS Registry Number:
  • Molecular Weight: 0

Related products

Select to

209810-58-2 Darbepoetin alfa

  • Darbepoetin alfa
  • China Finechemie Co., Ltd. [Manufacturer]
  • Tel: +86-23-99186710
  • Fax: +86-23-99186729
  • Address: 28th Floor Mordern Building,New-Tech Zone400020 ChongqingCHINA Chongqing,nullChina
Contact Supplier

209810-58-2 DARBEPOETINUM ALFA; [30-L-ASPARAGINE,32-L-THRONINE,87-L-VALINE,88-L-ASPARAGINE, 90-L-THREONINE]ERYTHROPOIETIN (HUMAN)

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

1/1
References of Erythropoietin[30-asparagine,32-threonine,87-valine,88-asparagine,90-threonine] (human)
Title: Darbepoetin Alfa
CAS Registry Number: 209810-58-2
CAS Name: [30-Asparagine,32-threonine,87-valine,88-asparagine,90-threonine]erythropoietin (human)
Synonyms: novel erythropoiesis stimulating protein; NESP
Trademarks: Aranesp (Amgen)
Literature References: Hyperglycosylated analog of human erythropoietin, q.v., produced by recombinant DNA technology. mol wt ~38 kDa. Engineered to contain 2 extra carbohydrate addition sites, leading to increased circulating half-life. Prepn: S. G. Elliott, T. E. Byrne, WO 9505465 (1995 to Amgen). Review of development and pharmacology: I. C. Macdougall, Semin. Nephrol. 20, 375-381 (2000); of clinical experience in treatment of anemia of kidney disease: A. R. Nissenson, Am. J. Kidney Dis. 38, 1390-1397 (2001); of chemotherapy induced anemia: J. Vansteenkiste, I. Wauters, Expert Opin. Pharmacother. 6, 429-440 (2005). Series of articles on clinical experience in cancer-related anemia: Br. J. Cancer 84, Suppl. 1, 1-38 (2001).
Therap-Cat: Hematopoietic.
Keywords: Hematopoietic.